Validation of the protein kinase PfCLK3 as a multi-stage cross species malarial drug target
Mahmood M Alam, Ana Sanchez-Azqueta, Omar Janha, Erika L. Flannery, Amit Mahindra, Kopano Mapesa, Nicolas Brancucci, Yevgeniya Antonova-Koch, Kathryn Crouch, Nelson Victor Simwela, Jude Akinwale, Deborah Mitcheson, Lev Solyakov, Kate Dudek, Carolyn Jones, , Andrew B. Tobin
This study identifies PfCLK3 as a druggable target for malaria by showing its essential role in multiple parasite life stages across species.
bioRxiv · Aug 31, 2018 · PreprintMicrobiology